<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34835107</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Nov</Month><Day>18</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>TDP-43 and HERV-K Envelope-Specific Immunogenic Epitopes Are Recognized in ALS Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2301</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v13112301</ELocationID><Abstract><AbstractText>The human endogenous retrovirus-K (HERV-K) and TAR DNA-binding protein 43 (TDP-43) have been associated with the pathophysiology of amyotrophic lateral sclerosis (ALS). Given these findings, we investigated the humoral response against HERV-K envelope surface (env-su) glycoprotein antigens and TDP-43 in the plasma of ALS patients and healthy controls (HCs). The measured levels of Abs against the different epitopes' fragments were significantly elevated in ALS patients, both in long-survivor (LS) and newly diagnosed (ND) patients, compared to HCs. We observed a positive correlation between HERV-K and TDP-43 antibodies (Abs) levels, which seemed to strengthen with disease progression, that was not found in HCs. The TDP-43 and HERV-K epitopes identified in this study are highly immunogenic and recognized by the humoral response of ALS patients. Increased circulating levels of Abs directed against specific HERV-K- and TDP-43-derived epitopes could serve as possible biomarkers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Simula</LastName><ForeName>Elena Rita</ForeName><Initials>ER</Initials><Identifier Source="ORCID">0000-0002-8946-2679</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Sassari, Viale San Pietro 43b, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arru</LastName><ForeName>Giannina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Clinical, Surgical and Experimental Sciences, University of Sassari, Viale San Pietro 8, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarbo</LastName><ForeName>Ignazio Roberto</ForeName><Initials>IR</Initials><AffiliationInfo><Affiliation>Department of Clinical, Surgical and Experimental Sciences, University of Sassari, Viale San Pietro 8, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solla</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-2982-0665</Identifier><AffiliationInfo><Affiliation>Department of Clinical, Surgical and Experimental Sciences, University of Sassari, Viale San Pietro 8, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sechi</LastName><ForeName>Leonardo A</ForeName><Initials>LA</Initials><Identifier Source="ORCID">0000-0003-0566-2049</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Sassari, Viale San Pietro 43b, 07100 Sassari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Struttura Complessa Microbiologia e Virologia, Azienda Ospedaliera Universitaria, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020077" MajorTopicYN="N">Endogenous Retroviruses</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">HERV-K</Keyword><Keyword MajorTopicYN="N">HML-2</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>27</Day><Hour>1</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34835107</ArticleId><ArticleId IdType="pmc">PMC8623164</ArticleId><ArticleId IdType="doi">10.3390/v13112301</ArticleId><ArticleId IdType="pii">v13112301</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rowland L.P., Shneider N.A. Medical Progress. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700.</Citation><ArticleIdList><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955.</Citation><ArticleIdList><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G., Traynor B.J., Hardiman O., Chio A., Mitchell D., Swingler R.J., Millul A., Benn E., Beghi E., Eurals F. Incidence of amyotrophic lateral sclerosis in Europe. J. Neurol. Neurosurg. Psychiatry. 2009;81:385&#x2013;390. doi: 10.1136/jnnp.2009.183525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.183525</ArticleId><ArticleId IdType="pmc">PMC2850819</ArticleId><ArticleId IdType="pubmed">19710046</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon P.H. Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials. Aging Dis. 2013;4:295&#x2013;310. doi: 10.14336/ad.2013.0400295.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/ad.2013.0400295</ArticleId><ArticleId IdType="pmc">PMC3794725</ArticleId><ArticleId IdType="pubmed">24124634</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin S., Al Khleifat A., Al-Chalabi A. What causes amyotrophic lateral sclerosis? F1000Research. 2017;6:371. doi: 10.12688/f1000research.10476.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.10476.1</ArticleId><ArticleId IdType="pmc">PMC5373425</ArticleId><ArticleId IdType="pubmed">28408982</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso A., Logroscino G., Hern&#xe1;n M. Smoking and the risk of amyotrophic lateral sclerosis: A systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry. 2010;81:1249&#x2013;1252. doi: 10.1136/jnnp.2009.180232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.180232</ArticleId><ArticleId IdType="pubmed">20639382</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarmeas N., Shih T., Stern Y., Ottman R., Rowland L.P. Premorbid weight, body mass, and varsity athletics in ALS. Neurology. 2002;59:773&#x2013;775. doi: 10.1212/wnl.59.5.773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.59.5.773</ArticleId><ArticleId IdType="pubmed">12221178</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozzoni V., Pansarasa O., Diamanti L., Nosari G., Cereda C., Ceroni M. Amyotrophic lateral sclerosis and environmental factors. Funct. Neurol. 2016;31:7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4819821</ArticleId><ArticleId IdType="pubmed">27027889</ArticleId></ArticleIdList></Reference><Reference><Citation>Capozzella A., Sacco C., Chighine A., Loreti B., Scala B., Casale T., Sinibaldi F., Tomei G., Giubilati R., Tomei F., et al. Work related etiology of amyotrophic lateral sclerosis (ALS): A meta-analysis. Ann. Ig. Med. Prev. Comunita. 2014;26:456&#x2013;472.</Citation><ArticleIdList><ArticleId IdType="pubmed">25405377</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes J.F., Coffin J.M. A Novel Endogenous Retrovirus-Related Element in the Human Genome Resembles a DNA Transposon: Evidence for an Evolutionary Link? Genomics. 2002;80:453&#x2013;455. doi: 10.1016/s0888-7543(02)96856-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0888-7543(02)96856-4</ArticleId><ArticleId IdType="pubmed">12408960</ArticleId></ArticleIdList></Reference><Reference><Citation>Douville R., Liu J., Rothstein J., Nath A. Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis. Ann. Neurol. 2010;69:141&#x2013;151. doi: 10.1002/ana.22149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22149</ArticleId><ArticleId IdType="pmc">PMC3052883</ArticleId><ArticleId IdType="pubmed">21280084</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Lee M.-H., Henderson L., Tyagi R., Bachani M., Steiner J., Campanac E., Hoffman D.A., von Geldern G., Johnson K., et al. Human endogenous retrovirus-K contributes to motor neuron disease. Sci. Transl. Med. 2015;7:307. doi: 10.1126/scitranslmed.aac8201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aac8201</ArticleId><ArticleId IdType="pmc">PMC6344353</ArticleId><ArticleId IdType="pubmed">26424568</ArticleId></ArticleIdList></Reference><Reference><Citation>Arru G., Mameli G., Deiana G.A., Rassu A.L., Piredda R., Sechi E., Caggiu E., Bo M., Nako E., Urso D., et al. Humoral immunity response to human endogenous retroviruses K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases. Eur. J. Neurol. 2018;25:1076-e84. doi: 10.1111/ene.13648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13648</ArticleId><ArticleId IdType="pubmed">29603839</ArticleId></ArticleIdList></Reference><Reference><Citation>Manghera M., Ferguson-Parry J., Douville R.N. TDP-43 regulates endogenous retrovirus-K viral protein accumulation. Neurobiol. Dis. 2016;94:226&#x2013;236. doi: 10.1016/j.nbd.2016.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.06.017</ArticleId><ArticleId IdType="pubmed">27370226</ArticleId></ArticleIdList></Reference><Reference><Citation>Douville R.N., Nath A. Human Endogenous Retrovirus-K and TDP-43 Expression Bridges ALS and HIV Neuropathology. Front. Microbiol. 2017;8:1986. doi: 10.3389/fmicb.2017.01986.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.01986</ArticleId><ArticleId IdType="pmc">PMC5641584</ArticleId><ArticleId IdType="pubmed">29075249</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A., Bharathi V., Sivalingam V., Girdhar A., Patel B.K. Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2019;12:25. doi: 10.3389/fnmol.2019.00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00025</ArticleId><ArticleId IdType="pmc">PMC6382748</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E., Baralle F.E. Characterization and Functional Implications of the RNA Binding Properties of Nuclear Factor TDP-43, a Novel Splicing Regulator ofCFTR Exon 9. J. Biol. Chem. 2001;276:36337&#x2013;36343. doi: 10.1074/jbc.m104236200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.m104236200</ArticleId><ArticleId IdType="pubmed">11470789</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson K.A., Kim S.H., Tibbetts R.S. RNA-binding proteins in neurodegenerative disease: TDP-43 and beyond. Wiley Interdiscip. Rev. RNA. 2011;3:265&#x2013;285. doi: 10.1002/wrna.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.111</ArticleId><ArticleId IdType="pmc">PMC3766724</ArticleId><ArticleId IdType="pubmed">22028183</ArticleId></ArticleIdList></Reference><Reference><Citation>Costessi L., Porro F., Iaconcig A., Muro A.F. TDP-43 regulates&#x3b2;-adducin(Add2) transcript stability. RNA Biol. 2014;11:1280&#x2013;1290. doi: 10.1080/15476286.2014.996081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2014.996081</ArticleId><ArticleId IdType="pmc">PMC4615836</ArticleId><ArticleId IdType="pubmed">25602706</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald K.K., Aulas A., Destroismaisons L., Pickles S., Beleac E., Camu W., Rouleau G.A., Velde C.V. TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. Hum. Mol. Genet. 2011;20:1400&#x2013;1410. doi: 10.1093/hmg/ddr021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr021</ArticleId><ArticleId IdType="pubmed">21257637</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B.D., Chitta R.K., High A.A., Taylor J.P. Global Analysis of TDP-43 Interacting Proteins Reveals Strong Association with RNA Splicing and Translation Machinery. J. Proteome Res. 2010;9:1104&#x2013;1120. doi: 10.1021/pr901076y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr901076y</ArticleId><ArticleId IdType="pmc">PMC2897173</ArticleId><ArticleId IdType="pubmed">20020773</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Xia P.Y., Zhou H. Sustained Expression of TDP-43 and FUS in Motor Neurons in Rodent&#x2019;s Lifetime. Int. J. Biol. Sci. 2010;6:396&#x2013;406. doi: 10.7150/ijbs.6.396.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.6.396</ArticleId><ArticleId IdType="pmc">PMC2899457</ArticleId><ArticleId IdType="pubmed">20616880</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton C.F., Good S.K., Atkin S., Dewey C.M., Mayer P., Herz J., Yu G. TDP-43 Is a Developmentally Regulated Protein Essential for Early Embryonic Development. J. Biol. Chem. 2010;285:6826&#x2013;6834. doi: 10.1074/jbc.m109.061846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.m109.061846</ArticleId><ArticleId IdType="pmc">PMC2825476</ArticleId><ArticleId IdType="pubmed">20040602</ArticleId></ArticleIdList></Reference><Reference><Citation>Winton M.J., Igaz L.M., Wong M.M., Kwong L.K., Trojanowski J.Q., Lee V.M.-Y. Disturbance of Nuclear and Cytoplasmic TAR DNA-binding Protein (TDP-43) Induces Disease-like Redistribution, Sequestration, and Aggregate Formation. J. Biol. Chem. 2008;283:13302&#x2013;13309. doi: 10.1074/jbc.m800342200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.m800342200</ArticleId><ArticleId IdType="pmc">PMC2442318</ArticleId><ArticleId IdType="pubmed">18305110</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala Y.M., Zago P., D&#x2019;Ambrogio A., Xu Y.-F., Petrucelli L., Buratti E., Baralle F.E. Structural determinants of the cellular localization and shuttling of TDP-43. J. Cell Sci. 2008;121:3778&#x2013;3785. doi: 10.1242/jcs.038950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.038950</ArticleId><ArticleId IdType="pubmed">18957508</ArticleId></ArticleIdList></Reference><Reference><Citation>Kametani F., Obi T., Shishido T., Akatsu H., Murayama S., Saito Y., Yoshida M., Hasegawa M. Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains. Sci. Rep. 2016;6:23281. doi: 10.1038/srep23281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23281</ArticleId><ArticleId IdType="pmc">PMC4793195</ArticleId><ArticleId IdType="pubmed">26980269</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E. TDP-43 post-translational modifications in health and disease. Expert Opin. Ther. Targets. 2018;22:279&#x2013;293. doi: 10.1080/14728222.2018.1439923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14728222.2018.1439923</ArticleId><ArticleId IdType="pubmed">29431050</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M., Arai T., Nonaka T., Kametani F., Yoshida M., Hashizume Y., Beach T.G., Buratti E., Baralle F., Morita M., et al. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 2008;64:60&#x2013;70. doi: 10.1002/ana.21425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21425</ArticleId><ArticleId IdType="pmc">PMC2674108</ArticleId><ArticleId IdType="pubmed">18546284</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Kwong L.K., Lee E.B., Kremmer E., Flatley A., Xu Y., Forman M.S., Troost D., Kretzschmar H.A., Trojanowski J.Q., et al. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 2009;117:137&#x2013;149. doi: 10.1007/s00401-008-0477-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0477-9</ArticleId><ArticleId IdType="pmc">PMC2693625</ArticleId><ArticleId IdType="pubmed">19125255</ArticleId></ArticleIdList></Reference><Reference><Citation>Inukai Y., Nonaka T., Arai T., Yoshida M., Hashizume Y., Beach T.G., Buratti E., Baralle F.E., Akiyama H., Hisanaga S.-I., et al. Abnormal phosphorylation of Ser409/410 of TDP-43 in FTLD-U and ALS. FEBS Lett. 2008;582:2899&#x2013;2904. doi: 10.1016/j.febslet.2008.07.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2008.07.027</ArticleId><ArticleId IdType="pubmed">18656473</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J., Wang W., Miao S., Chen F., Wu F., Hu W., Iqbal K., Gong C.-X., Liu F. Protein Phosphatase 1 dephosphorylates TDP-43 and suppresses its function in tau exon 10 inclusion. FEBS Lett. 2018;592:402&#x2013;410. doi: 10.1002/1873-3468.12976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.12976</ArticleId><ArticleId IdType="pubmed">29334120</ArticleId></ArticleIdList></Reference><Reference><Citation>Kametani F., Nonaka T., Suzuki T., Arai T., Dohmae N., Akiyama H., Hasegawa M. Identification of casein kinase-1 phosphorylation sites on TDP-43. Biochem. Biophys. Res. Commun. 2009;382:405&#x2013;409. doi: 10.1016/j.bbrc.2009.03.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2009.03.038</ArticleId><ArticleId IdType="pubmed">19285963</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh C.W., Lee I.C.J., Sundaram J.R., George S.E., Yusoff P., Brush M.H., Sze S.K., Shenolikar S. Chronic oxidative stress promotes GADD34-mediated phosphorylation of the TAR DNA-binding protein TDP-43, a modification linked to neurodegeneration. J. Biol. Chem. 2018;293:163&#x2013;176. doi: 10.1074/jbc.m117.814111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.m117.814111</ArticleId><ArticleId IdType="pmc">PMC5766914</ArticleId><ArticleId IdType="pubmed">29109149</ArticleId></ArticleIdList></Reference><Reference><Citation>Radunovi&#x107; A., Mitsumoto H., Leigh P.N. Clinical care of patients with amyotrophic lateral sclerosis. Lancet Neurol. 2007;6:913&#x2013;925. doi: 10.1016/s1474-4422(07)70244-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(07)70244-2</ArticleId><ArticleId IdType="pubmed">17884681</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti E., Sala G., Diamanti S., Casati M., Lunetta C., Gerardi F., Tarlarini C., Mosca L., Riva N., Falzone Y., et al. Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis. Sci. Rep. 2021;11:1&#x2013;6. doi: 10.1038/s41598-021-81599-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-81599-5</ArticleId><ArticleId IdType="pmc">PMC7820419</ArticleId><ArticleId IdType="pubmed">33479441</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen A.K., Folke J., Owczarek S., Svenstrup K., Winge K., Pakkenberg B., Aznar S., Brudek T. TDP-43&#x2013;specific Autoantibody Decline in Patients with Amyotrophic Lateral Sclerosis. Neurol. Neuroimmunol. Neuroinflammation. 2021;8:e937. doi: 10.1212/nxi.0000000000000937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/nxi.0000000000000937</ArticleId><ArticleId IdType="pmc">PMC7768943</ArticleId><ArticleId IdType="pubmed">33361387</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstraete E., Kuiperij B., van Blitterswijk M., Veldink J.H., Schelhaas H.J., Berg L.H.V.D., Verbeek M.M. TDP-43 plasma levels are higher in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2012;13:446&#x2013;451. doi: 10.3109/17482968.2012.703208.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.703208</ArticleId><ArticleId IdType="pubmed">22873561</ArticleId></ArticleIdList></Reference><Reference><Citation>Foulds P., McAuley E., Gibbons L., Davidson Y., Pickering-Brown S.M., Neary D., Snowden J.S., Allsop D., Mann D.M.A. TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer&#x2019;s disease and frontotemporal lobar degeneration. Acta Neuropathol. 2008;116:141&#x2013;146. doi: 10.1007/s00401-008-0389-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0389-8</ArticleId><ArticleId IdType="pmc">PMC2464623</ArticleId><ArticleId IdType="pubmed">18506455</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q., Lehmer C., Michaelsen M., Mori K., Alterauge D., Baumjohann D., Schludi M.H., Greiling J., Farny D., Flatley A., et al. Antibodies inhibit transmission and aggregation of C9orf72 poly- GA dipeptide repeat proteins. EMBO Mol. Med. 2017;9:687&#x2013;702. doi: 10.15252/emmm.201607054.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201607054</ArticleId><ArticleId IdType="pmc">PMC5412769</ArticleId><ArticleId IdType="pubmed">28351931</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison A.F., Shorter J. RNA-binding proteins with prion-like domains in health and disease. Biochem. J. 2017;474:1417&#x2013;1438. doi: 10.1042/bcj20160499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bcj20160499</ArticleId><ArticleId IdType="pmc">PMC5639257</ArticleId><ArticleId IdType="pubmed">28389532</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>